Anti-Retropulsion Devices Market Report 2024

The anti-retropulsion devices market size has grown strongly in recent years. It will grow from $2.24 billion in 2023 to $2.4 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth during the historical period can be explained by several factors, including the rising incidence of kidney stones, increasing demand for minimally invasive procedures, improvements in global healthcare infrastructure, advancements in regulatory approvals and standards, and the expanding elderly population.

The anti-retropulsion devices market size is expected to see strong growth in the next few years. It will grow to $3.2 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. Anticipated growth in the forecast period is driven by the expansion of healthcare infrastructure in emerging markets, supportive regulatory measures, the expansion of healthcare facilities, increasing awareness and education, and a shift towards outpatient procedures. Key trends expected in this period include technological advancements, innovations in device design and materials, robotics and automation, development of biodegradable devices, and personalized patient solutions.

The increasing incidence of chronic kidney disease is expected to drive the expansion of the anti-retropulsion device market in the future. Chronic kidney diseases encompass a variety of conditions affecting kidney structure and function. Factors such as poor dietary habits, lack of physical activity, obesity, smoking, and excessive alcohol consumption contribute to the rise in renal disorders. Anti-retropulsion devices play a crucial role in improving the efficacy of urological procedures by preventing kidney stone fragments from moving back toward the kidney during treatment. For example, in February 2023, the Australian Institute of Health and Welfare reported that hospitalizations for chronic kidney disease as the primary diagnosis (excluding dialysis) increased from 197 to 205 per 100,000 people between 2020 and 2021. Additionally, the number of individuals undergoing kidney replacement therapy rose from 94 in 2019 to 95 in 2021 per 100,000 people. Hence, the growing prevalence of chronic kidney disease is set to propel the anti-retropulsion device market forward.

Key players in the anti-retropulsion device market are focusing on enhancing design and innovating user-centric solutions, such as vacuum-assisted kidney stone removal devices, to improve patient outcomes and reduce procedural times. These medical tools use suction to capture and remove kidney stones from the urinary tract, enhancing the efficiency of urological procedures. For instance, in March 2024, Calyxo, Inc., a US-based medical device company, launched the CVAC System, designed for efficient kidney stone removal using irrigation and vacuum aspiration during and after laser lithotripsy, aiming for stone-free outcomes.

In September 2021, Boston Scientific, a global medical technology company, acquired the surgical business of Lumenis Ltd. for $1.07 billion. This acquisition integrates Lumenis' laser technology, including MOSES technology, into Boston Scientific's offerings for kidney stone management and benign prostatic hyperplasia. It strengthens Boston Scientific's presence in Europe and Asia, leveraging Lumenis' expertise in anti-retropulsion medical devices for kidney stone treatment.

Major companies operating in the anti-retropulsion devices market are Johnson & Johnson, Medtronic plc, Fujifilm Holdings Corporation, Becton Dickinson and Company, Boston Scientific Corporation, Olympus Corporation, STERIS Corporation, C.R. Bard Inc., Coloplast A/S, Teleflex Incorporated, Cook Medical Incorporated, Karl Storz SE & Co. KG, Merit Medical Systems Inc., Ambu A/S, Applied Medical Resources Corporation, Gyrus ACMI Inc., Dornier MedTech GmbH, Accordion Medical LLC, Cogentix Medical Inc., Biolitec AG, ROCAMED SAM, blueneem Medical Devices Pvt. Ltd., Elmed Medical Systems Inc., Endotherapeutics Pty Ltd, Maxer Endoscopy GmbH.

North America was the largest region in the anti-retropulsion devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-retropulsion devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the anti-retropulsion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Anti-retropulsion devices are instruments utilized in medical procedures, particularly in urology, to prevent kidney stones or fragments from moving back up the ureter towards the kidney during lithotripsy or other stone removal procedures. These tools stabilize stones or fragments within the urinary tract, aiding their passage or extraction without causing obstruction or complications.

The primary types of anti-retropulsion devices include basket-type, balloon-type, and other specialized variants. Basket-type devices are specifically designed for urological procedures to capture and remove kidney stones or fragments. These devices find applications in ureteroscopy, lithotripsy, and are used in settings such as hospitals and ambulatory surgical centers.

The anti-retropulsion devices market research report is one of a series of new reports that provides anti-retropulsion devices market statistics, including anti-retropulsion devices industry global market size, regional shares, competitors with an anti-retropulsion devices market share, detailed anti-retropulsion devices market segments, market trends and opportunities, and any further data you may need to thrive in the anti-retropulsion devices industry. This anti-retropulsion devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anti-retropulsion devices market consists of sales of retrieval baskets, ureteral access sheaths, and tipless nitinol stone baskets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.